[1]
M. Marjani, “Evaluation of silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial”, Gastroenterol Hepatol Bed Bench, vol. 12, no. 2, pp. 138–142, Mar. 2019.